Molecular Medicine Reports · 2014 · 18 citations · 28 references
Life SciencesCell BiologyImmunologyApoptosisCancer ImmunologyImmunoregulationApoptosis In Immune CellsCancer ImmunotherapyCell-mediated ImmunityImmunosuppressionRegulatory T CellsT Cell BiologyDendritic Cell ApoptosisDendritic Cell Tolerogenic FunctionFas LigandFas Ligand-mediated ApoptosisImmunosuppressive FunctionRegulatory T Cell ApoptosisTolerogenic Dendritic CellsTransforming Growth Factor Beta-mediated Immune Suppression
Although tumor cell lysate (TCL) is a type of immunocyte stimulator, its immunosuppressive function must not be ignored. The present study reported that TCL prepared from a Lewis lung cancer cell was able to induce the development of immunosuppressive macrophages (MΦ) and tolerogenic dendritic cells. In addition, TCL upregulated the expression of CD69 in mouse splenocytes, and cell apoptosis and the percentage of regulatory T cells in mouse splenocytes simultaneously increased. Furthermore, the present study found that the immunosuppressive factor, hyaluronan, and the apoptosis inducers, Fas ligand and transforming growth factor-β, are present in TCL. These components may be associated with the emergence of immunosuppressive cells or splenocyte apoptosis. Thus, the present study has enriched our understanding of the composition of TCL and its negative regulatory effect on immunocytes.
28
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Honglin Li, Hong Zhu, Chi-jie Xu et al. · Cell · 1998 · 4.4K citations · Full text
Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Michael Hahne, Donata Rimoldi, Michael Schröter et al. · Science · 1996 · 1.3K citations
Life Sciences, Immunology, Oncology +17
Human lung carcinomas express Fas ligand.
G A Niehans, Thomas Brunner, Sandra Frizelle et al. · PubMed · 1997 · 396 citations · Full text
Life Sciences, Immunology, Oncology +17